{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:37:30Z","timestamp":1790422650267,"version":"4.1.0"},"reference-count":72,"publisher":"American Society of Hematology","issue":"2","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,1,23]]},"abstract":"<jats:title>Key Points<\/jats:title>\n               <jats:p>Clinical response of SSc patients after AHSCT is associated with thymic and bone marrow rebounds. Responder patients showed higher Treg and Breg counts and lower pre-\/post-AHSCT TCR repertoire overlap than nonresponder patients.<\/jats:p>","DOI":"10.1182\/bloodadvances.2017011072","type":"journal-article","created":{"date-parts":[[2018,3,12]],"date-time":"2018-03-12T10:07:24Z","timestamp":1520849244000},"page":"126-141","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":85,"title":["Immune rebound associates with a favorable clinical response to autologous HSCT in systemic sclerosis patients"],"prefix":"10.1182","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8573-9618","authenticated-orcid":false,"given":"Lucas C. M.","family":"Arruda","sequence":"first","affiliation":[{"name":"Basic and Applied Immunology Program, Ribeir\u00e3o Preto Medical School,"},{"name":"Center for Cell-based Therapy, Regional Hemotherapy Center of the Ribeir\u00e3o Preto Medical School,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9303-0086","authenticated-orcid":false,"given":"Kelen C. R.","family":"Malmegrim","sequence":"additional","affiliation":[{"name":"Center for Cell-based Therapy, Regional Hemotherapy Center of the Ribeir\u00e3o Preto Medical School,"},{"name":"Department of Clinical, Toxicological and Bromatological Analysis, School of Pharmaceutical Sciences of Ribeir\u00e3o Preto, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joa\u0303o R.","family":"Lima-Ju\u0301nior","sequence":"additional","affiliation":[{"name":"Center for Cell-based Therapy, Regional Hemotherapy Center of the Ribeir\u00e3o Preto Medical School,"},{"name":"Graduate Program on Bioscience Applied to Pharmacy, School of Pharmaceutical Sciences of Ribeir\u00e3o Preto, University of S\u00e3o Paulo, Ribeir\u00e3o Preto, Brazil;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Clave","sequence":"additional","affiliation":[{"name":"INSERM Unit\u00e9 Mixte de Recherche 1160, Institut Universitaire d\u2019H\u00e9matologie, H\u00f4pital Saint-Louis, Assistance Publique\u2013H\u00f4pitaux de Paris (AP-HP), Paris, France;"},{"name":"Institut Universitaire d'H\u00e9matologie, Universit\u00e9 Paris Diderot, Sorbonne Paris Cit\u00e9, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana B. E.","family":"Dias","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Ribeir\u00e3o Preto Medical School, University of S\u00e3o Paulo, Ribeir\u00e3o Preto, Brazil;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela A.","family":"Moraes","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Ribeir\u00e3o Preto Medical School, University of S\u00e3o Paulo, Ribeir\u00e3o Preto, Brazil;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Douay","sequence":"additional","affiliation":[{"name":"INSERM Unit\u00e9 Mixte de Recherche 1160, Institut Universitaire d\u2019H\u00e9matologie, H\u00f4pital Saint-Louis, Assistance Publique\u2013H\u00f4pitaux de Paris (AP-HP), Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Fournier","sequence":"additional","affiliation":[{"name":"INSERM Unit\u00e9 Mixte de Recherche 1160, Institut Universitaire d\u2019H\u00e9matologie, H\u00f4pital Saint-Louis, Assistance Publique\u2013H\u00f4pitaux de Paris (AP-HP), Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He\u0301le\u0300ne","family":"Moins-Teisserenc","sequence":"additional","affiliation":[{"name":"INSERM Unit\u00e9 Mixte de Recherche 1160, Institut Universitaire d\u2019H\u00e9matologie, H\u00f4pital Saint-Louis, Assistance Publique\u2013H\u00f4pitaux de Paris (AP-HP), Paris, France;"},{"name":"Institut Universitaire d'H\u00e9matologie, Universit\u00e9 Paris Diderot, Sorbonne Paris Cit\u00e9, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ant\u00f4nio Jos\u00e9","family":"Alberdi","sequence":"additional","affiliation":[{"name":"Institut Universitaire d'H\u00e9matologie, Universit\u00e9 Paris Diderot, Sorbonne Paris Cit\u00e9, Paris, France;"},{"name":"Plateforme Technologique, Institut Universitaire d'H\u00e9matologie, Paris, France; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimas T.","family":"Covas","sequence":"additional","affiliation":[{"name":"Center for Cell-based Therapy, Regional Hemotherapy Center of the Ribeir\u00e3o Preto Medical School,"},{"name":"Department of Internal Medicine, Ribeir\u00e3o Preto Medical School, University of S\u00e3o Paulo, Ribeir\u00e3o Preto, Brazil;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belinda P.","family":"Sim\u00f5es","sequence":"additional","affiliation":[{"name":"Center for Cell-based Therapy, Regional Hemotherapy Center of the Ribeir\u00e3o Preto Medical School,"},{"name":"Department of Internal Medicine, Ribeir\u00e3o Preto Medical School, University of S\u00e3o Paulo, Ribeir\u00e3o Preto, Brazil;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Lansiaux","sequence":"additional","affiliation":[{"name":"Unit\u00e9 de M\u00e9decine Interne, Maladies Autoimmunes et Pathologie Vasculaire, UF 04, AP-HP, Centre de r\u00e9f\u00e9rence des maladies auto-immunes syst\u00e9miques rares d\u2019Ile-de-France (site constitutif), FAI2R, H\u00f4pital Saint-Louis, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7308-7317","authenticated-orcid":false,"given":"Antoine","family":"Toubert","sequence":"additional","affiliation":[{"name":"INSERM Unit\u00e9 Mixte de Recherche 1160, Institut Universitaire d\u2019H\u00e9matologie, H\u00f4pital Saint-Louis, Assistance Publique\u2013H\u00f4pitaux de Paris (AP-HP), Paris, France;"},{"name":"Institut Universitaire d'H\u00e9matologie, Universit\u00e9 Paris Diderot, Sorbonne Paris Cit\u00e9, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0691-2222","authenticated-orcid":false,"given":"Maria Carolina","family":"Oliveira","sequence":"additional","affiliation":[{"name":"Basic and Applied Immunology Program, Ribeir\u00e3o Preto Medical School,"},{"name":"Center for Cell-based Therapy, Regional Hemotherapy Center of the Ribeir\u00e3o Preto Medical School,"},{"name":"Department of Internal Medicine, Ribeir\u00e3o Preto Medical School, University of S\u00e3o Paulo, Ribeir\u00e3o Preto, Brazil;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2018,1,17]]},"reference":[{"issue":"10103","key":"2019111617453283500_B1","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"390","author":"Denton","year":"2017","journal-title":"Lancet"},{"issue":"19","key":"2019111617453283500_B2","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1056\/NEJMra0806188","article-title":"Scleroderma","volume":"360","author":"Gabrielli","year":"2009","journal-title":"N Engl J Med"},{"issue":"5","key":"2019111617453283500_B3","doi-asserted-by":"crossref","first-page":"R124","DOI":"10.1186\/ar2534","article-title":"Effects of cyclophosphamide on pulmonary function in patients with scleroderma and interstitial lung disease: a systematic review and meta-analysis of randomized controlled trials and observational prospective cohort studies","volume":"10","author":"Nannini","year":"2008","journal-title":"Arthritis Res Ther"},{"issue":"25","key":"2019111617453283500_B4","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1056\/NEJMoa055120","article-title":"Cyclophosphamide versus placebo in scleroderma lung disease","volume":"354","author":"Tashkin","year":"2006","journal-title":"N Engl J Med"},{"issue":"9","key":"2019111617453283500_B5","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S2213-2600(16)30152-7","article-title":"Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial","volume":"4","author":"Tashkin","year":"2016","journal-title":"Lancet Respir Med"},{"issue":"7","key":"2019111617453283500_B6","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1002\/art.40114","article-title":"Mycophenolate mofetil versus placebo for systemic sclerosis-related interstitial lung disease: an analysis of scleroderma lung studies I and II","volume":"69","author":"Volkmann","year":"2017","journal-title":"Arthritis Rheumatol"},{"issue":"9790","key":"2019111617453283500_B7","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0140-6736(11)60982-3","article-title":"Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial","volume":"378","author":"Burt","year":"2011","journal-title":"Lancet"},{"issue":"24","key":"2019111617453283500_B8","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1001\/jama.2014.6368","article-title":"Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial","volume":"311","author":"van Laar","year":"2014","journal-title":"JAMA"},{"issue":"10","key":"2019111617453283500_B9","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1002\/art.39748","article-title":"Review: hematopoietic stem cell transplantation for scleroderma: effective immunomodulatory therapy for patients with pulmonary involvement","volume":"68","author":"Sullivan","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"2019111617453283500_B10","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/j.bbmt.2017.01.012","article-title":"Myeloablative autologous transplantation of CD34+ selected hematopoietic stem cells (HSCT) vs monthly intravenous cyclophosphamide (CY) for severe scleroderma with internal organ involvement: outcomes of a randomized North American clinical trial","volume":"23","author":"Sullivan","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"2019111617453283500_B11","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1038\/bmt.2017.56","article-title":"Cardiopulmonary assessment of patients with systemic sclerosis for hematopoietic stem cell transplantation\u202f: recommendations from the European Society for Blood and Marrow Transplantation Autoimmune Diseases Working Party and collaborating partners","volume":"52","author":"Farge","year":"2017","journal-title":"Bone Marrow Transpl"},{"issue":"6","key":"2019111617453283500_B12","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/bmt.2011.185","article-title":"Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation","volume":"47","author":"Snowden","year":"2012","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"2019111617453283500_B13","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/bmt.2014.251","article-title":"SCT for severe autoimmune diseases: consensus guidelines of the European Society for Blood and Marrow Transplantation for immune monitoring and biobanking","volume":"50","author":"Alexander","year":"2015","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"2019111617453283500_B14","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/bmt.2013.202","article-title":"Peripheral blood regulatory T cells in patients with diffuse systemic sclerosis (SSc) before and after autologous hematopoietic SCT: a pilot study","volume":"49","author":"Baraut","year":"2014","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"2019111617453283500_B15","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3109\/03009742.2010.528021","article-title":"Altered T-cell and regulatory cell repertoire in patients with diffuse cutaneous systemic sclerosis","volume":"40","author":"Papp","year":"2011","journal-title":"Scand J Rheumatol"},{"issue":"11","key":"2019111617453283500_B16","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.clim.2017.05.013","article-title":"Increased proportions of functionally impaired regulatory T cell subsets in systemic sclerosis","volume":"184","author":"Ugor","year":"2017","journal-title":"Clin Immunol"},{"issue":"2","key":"2019111617453283500_B17","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/jid.2009.313","article-title":"CD127(low\/-) and FoxP3(+) expression levels characterize different regulatory T-cell populations in human peripheral blood","volume":"130","author":"Klein","year":"2010","journal-title":"J Invest Dermatol"},{"issue":"3","key":"2019111617453283500_B18","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.clim.2009.08.010","article-title":"Study of thymic size and function in children and adolescents with treatment refractory systemic sclerosis eligible for immunoablative therapy","volume":"133","author":"Reiff","year":"2009","journal-title":"Clin Immunol"},{"issue":"5","key":"2019111617453283500_B19","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1002\/art.21036","article-title":"Analysis of immune reconstitution after autologous bone marrow transplantation in systemic sclerosis","volume":"52","author":"Farge","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"2","key":"2019111617453283500_B20","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.autrev.2015.10.005","article-title":"Systemic sclerosis: New evidence re-enforces the role of B cells","volume":"15","author":"Sakkas","year":"2016","journal-title":"Autoimmun Rev"},{"issue":"6","key":"2019111617453283500_B21","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1002\/art.20274","article-title":"Altered blood B lymphocyte homeostasis in systemic sclerosis: expanded naive B cells and diminished but activated memory B cells","volume":"50","author":"Sato","year":"2004","journal-title":"Arthritis Rheum"},{"key":"2019111617453283500_B22","doi-asserted-by":"crossref","first-page":"496","DOI":"10.3389\/fimmu.2015.00496","article-title":"Systemic sclerosis patients present alterations in the expression of molecules involved in B-cell regulation","volume":"6","author":"Soto","year":"2015","journal-title":"Front Immunol"},{"issue":"5 Suppl 100","key":"2019111617453283500_B23","first-page":"30","article-title":"Reduced non-switched memory B cell subsets cause imbalance in B cell repertoire in systemic sclerosis","volume":"34","author":"Simon","year":"2016","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"2019111617453283500_B24","doi-asserted-by":"crossref","first-page":"15002","DOI":"10.1038\/nrdp.2015.2","article-title":"Systemic sclerosis","volume":"1","author":"Allanore","year":"2015","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"2019111617453283500_B25","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/art.39437","article-title":"Breg cells are numerically decreased and functionally impaired in patients with systemic sclerosis","volume":"68","author":"Mavropoulos","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"2019111617453283500_B26","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/rheumatology\/kev331","article-title":"Decreased levels of regulatory B cells in patients with systemic sclerosis: association with autoantibody production and disease activity","volume":"55","author":"Matsushita","year":"2016","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"2019111617453283500_B27","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1084\/jem.20041679","article-title":"Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients","volume":"201","author":"Muraro","year":"2005","journal-title":"J Exp Med"},{"issue":"3","key":"2019111617453283500_B28","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1172\/JCI71691","article-title":"T cell repertoire following autologous stem cell transplantation for multiple sclerosis","volume":"124","author":"Muraro","year":"2014","journal-title":"J Clin Invest"},{"issue":"10","key":"2019111617453283500_B29","doi-asserted-by":"crossref","first-page":"6346","DOI":"10.4049\/jimmunol.0901773","article-title":"Regulatory T cell (Treg) subsets return in patients with refractory lupus following stem cell transplantation, and TGF-beta-producing CD8+ Treg cells are associated with immunological remission of lupus","volume":"183","author":"Zhang","year":"2009","journal-title":"J Immunol"},{"issue":"1","key":"2019111617453283500_B30","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1182\/blood-2008-07-168286","article-title":"Depletion of autoreactive immunologic memory followed by autologous hematopoietic stem cell transplantation in patients with refractory SLE induces long-term remission through de novo generation of a juvenile and tolerant immune system","volume":"113","author":"Alexander","year":"2009","journal-title":"Blood"},{"issue":"4","key":"2019111617453283500_B31","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1182\/blood-2005-07-2800","article-title":"Autologous stem cell transplantation for autoimmunity induces immunologic self-tolerance by reprogramming autoreactive T cells and restoring the CD4+CD25+ immune regulatory network","volume":"107","author":"de Kleer","year":"2006","journal-title":"Blood"},{"issue":"12","key":"2019111617453283500_B32","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.dld.2011.07.021","article-title":"Immunomodulatory effects of unselected haematopoietic stem cells autotransplantation in refractory Crohn\u2019s disease","volume":"43","author":"Clerici","year":"2011","journal-title":"Dig Liver Dis"},{"issue":"1","key":"2019111617453283500_B33","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13045-016-0388-5","article-title":"Long-term immune reconstitution and T cell repertoire analysis after autologous hematopoietic stem cell transplantation in systemic sclerosis patients","volume":"10","author":"Farge","year":"2017","journal-title":"J Hematol Oncol"},{"issue":"11","key":"2019111617453283500_B34","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative","volume":"65","author":"van den Hoogen","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"9872","key":"2019111617453283500_B35","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/S0140-6736(12)62114-X","article-title":"Cardiac involvement and treatment-related mortality after non-myeloablative haemopoietic stem-cell transplantation with unselected autologous peripheral blood for patients with systemic sclerosis: a retrospective analysis","volume":"381","author":"Burt","year":"2013","journal-title":"Lancet"},{"issue":"3","key":"2019111617453283500_B36","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/bmt.2014.277","article-title":"Autologous hematopoietic SCT normalizes miR-16, -155 and -142-3p expression in multiple sclerosis patients","volume":"50","author":"Arruda","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"2019111617453283500_B37","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.clim.2016.06.005","article-title":"Immunological correlates of favorable long-term clinical outcome in multiple sclerosis patients after autologous hematopoietic stem cell transplantation","volume":"169","author":"Arruda","year":"2016","journal-title":"Clin Immunol"},{"key":"2019111617453283500_B38","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3389\/fimmu.2017.00167","article-title":"Immunological balance is associated with clinical outcome after autologous hematopoietic stem cell transplantation in type 1 diabetes","volume":"8","author":"Malmegrim","year":"2017","journal-title":"Front Immunol"},{"key":"2019111617453283500_B39","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3389\/fimmu.2013.00054","article-title":"Thymic function recovery after unrelated donor cord blood or T-cell depleted HLA-haploidentical stem cell transplantation correlates with leukemia relapse","volume":"4","author":"Clave","year":"2013","journal-title":"Front Immunol"},{"issue":"15","key":"2019111617453283500_B40","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1182\/blood-2014-05-573303","article-title":"Impact of acute and chronic graft-versus-host disease on human B-cell generation and replication","volume":"124","author":"Glauzy","year":"2014","journal-title":"Blood"},{"issue":"25","key":"2019111617453283500_B41","doi-asserted-by":"crossref","first-page":"6477","DOI":"10.1182\/blood-2008-09-176594","article-title":"Acute graft-versus-host disease transiently impairs thymic output in young patients after allogeneic hematopoietic stem cell transplantation","volume":"113","author":"Clave","year":"2009","journal-title":"Blood"},{"issue":"11","key":"2019111617453283500_B42","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1182\/blood-2014-09-599159","article-title":"CD24(hi)CD27+ and plasmablast-like regulatory B cells in human chronic graft-versus-host disease","volume":"125","author":"de Masson","year":"2015","journal-title":"Blood"},{"key":"2019111617453283500_B43","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1146\/annurev-immunol-020711-074934","article-title":"Immune regulatory function of B cells","volume":"30","author":"Mauri","year":"2012","journal-title":"Annu Rev Immunol"},{"key":"2019111617453283500_B44","doi-asserted-by":"crossref","first-page":"456","DOI":"10.3389\/fimmu.2013.00456","article-title":"Preparing unbiased T-cell receptor and antibody cDNA libraries for the deep next generation sequencing profiling","volume":"4","author":"Mamedov","year":"2013","journal-title":"Front Immunol"},{"issue":"13","key":"2019111617453283500_B45","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1093\/bioinformatics\/btu138","article-title":"pRESTO: a toolkit for processing high-throughput sequencing raw reads of lymphocyte receptor repertoires","volume":"30","author":"Vander Heiden","year":"2014","journal-title":"Bioinformatics"},{"issue":"9","key":"2019111617453283500_B46","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/nmeth.2555","article-title":"MiTCR: software for T-cell receptor sequencing data analysis","volume":"10","author":"Bolotin","year":"2013","journal-title":"Nat Methods"},{"issue":"11","key":"2019111617453283500_B47","doi-asserted-by":"crossref","first-page":"e1004503","DOI":"10.1371\/journal.pcbi.1004503","article-title":"VDJtools: unifying post-analysis of T cell receptor repertoires","volume":"11","author":"Shugay","year":"2015","journal-title":"PLOS Comput Biol"},{"issue":"2","key":"2019111617453283500_B48","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1399-0039.2011.01820.x","article-title":"Thymus and immune reconstitution after allogeneic hematopoietic stem cell transplantation in humans: never say never again","volume":"79","author":"Toubert","year":"2012","journal-title":"Tissue Antigens"},{"issue":"6","key":"2019111617453283500_B49","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1084\/jem.20011756","article-title":"Two subsets of naive T helper cells with distinct T cell receptor excision circle content in human adult peripheral blood","volume":"195","author":"Kimmig","year":"2002","journal-title":"J Exp Med"},{"issue":"1","key":"2019111617453283500_B50","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1146\/annurev.immunol.22.012703.104702","article-title":"Central memory and effector memory T cell subsets: function, generation, and maintenance","volume":"22","author":"Sallusto","year":"2004","journal-title":"Annu Rev Immunol"},{"issue":"4","key":"2019111617453283500_B51","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/emmm.201100129","article-title":"Quantitative tracking of T cell clones after haematopoietic stem cell transplantation","volume":"3","author":"Mamedov","year":"2011","journal-title":"EMBO Mol Med"},{"issue":"1","key":"2019111617453283500_B52","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/jpe\/rtr044","article-title":"Models and estimators linking individual-based and sample-based rarefaction, extrapolation and comparison of assemblages","volume":"5","author":"Colwell","year":"2012","journal-title":"J Plant Ecol"},{"issue":"3","key":"2019111617453283500_B53","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1084\/jem.20060964","article-title":"Replication history of B lymphocytes reveals homeostatic proliferation and extensive antigen-induced B cell expansion","volume":"204","author":"van Zelm","year":"2007","journal-title":"J Exp Med"},{"issue":"7","key":"2019111617453283500_B54","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.4049\/jimmunol.167.7.3610","article-title":"Bm1-Bm5 classification of peripheral blood B cells reveals circulating germinal center founder cells in healthy individuals and disturbance in the B cell subpopulations in patients with primary Sj\u00f6gren\u2019s syndrome","volume":"167","author":"Bohnhorst","year":"2001","journal-title":"J Immunol"},{"issue":"2","key":"2019111617453283500_B55","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.retram.2016.03.004","article-title":"Resetting the immune response after autologous hematopoietic stem cell transplantation for autoimmune diseases","volume":"64","author":"Arruda","year":"2016","journal-title":"Curr Res Transl Med"},{"issue":"7","key":"2019111617453283500_B56","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/nrneurol.2017.81","article-title":"Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis","volume":"13","author":"Muraro","year":"2017","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"2019111617453283500_B57","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/nrrheum.2017.7","article-title":"Haematopoietic stem cell transplantation for autoimmune diseases","volume":"13","author":"Swart","year":"2017","journal-title":"Nat Rev Rheumatol"},{"issue":"5","key":"2019111617453283500_B58","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1093\/rheumatology\/keq414","article-title":"Analysis of immune reconstitution after autologous CD34+ stem\/progenitor cell transplantation for systemic sclerosis: predominant reconstitution of Th1 CD4+ T cells","volume":"50","author":"Tsukamoto","year":"2011","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"2019111617453283500_B59","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.3899\/jrheum.081025","article-title":"Immunological reconstitution after autologous hematopoietic stem cell transplantation in patients with systemic sclerosis: relationship between clinical benefits and intensity of immunosuppression","volume":"36","author":"Bohgaki","year":"2009","journal-title":"J Rheumatol"},{"issue":"8","key":"2019111617453283500_B60","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1038\/bmt.2016.77","article-title":"Evolution of serum cytokine profile after hematopoietic stem cell transplantation in systemic sclerosis patients","volume":"51","author":"Michel","year":"2016","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"2019111617453283500_B61","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/bmt.2009.139","article-title":"T-cell clones persisting in the circulation after autologous hematopoietic SCT are undetectable in the peripheral CD34+ selected graft","volume":"45","author":"Dubinsky","year":"2010","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"2019111617453283500_B62","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1046\/j.1365-2141.2002.03895.x","article-title":"Autologous bone marrow transplantation in the treatment of refractory systemic sclerosis: early results from a French multicentre phase I-II study","volume":"119","author":"Farge","year":"2002","journal-title":"Br J Haematol"},{"issue":"4","key":"2019111617453283500_B63","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/bmt.2015.299","article-title":"Does ex vivo CD34+ positive selection influence outcome after autologous hematopoietic stem cell transplantation in systemic sclerosis patients?","volume":"51","author":"Oliveira","year":"2016","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"2019111617453283500_B64","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1182\/blood-2015-06-649145","article-title":"Autologous stem cell transplantation aids autoimmune patients by functional renewal and TCR diversification of regulatory T cells","volume":"127","author":"Delemarre","year":"2016","journal-title":"Blood"},{"issue":"Pt 9","key":"2019111617453283500_B65","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1093\/brain\/awt182","article-title":"Non-myeloablative autologous haematopoietic stem cell transplantation expands regulatory cells and depletes IL-17 producing mucosal-associated invariant T cells in multiple sclerosis","volume":"136","author":"Abrahamsson","year":"2013","journal-title":"Brain"},{"issue":"26","key":"2019111617453283500_B66","doi-asserted-by":"crossref","first-page":"6123","DOI":"10.1182\/blood-2010-06-292391","article-title":"Autologous nonmyeloablative hematopoietic stem cell transplantation in patients with severe anti-TNF refractory Crohn disease: long-term follow-up","volume":"116","author":"Burt","year":"2010","journal-title":"Blood"},{"issue":"3","key":"2019111617453283500_B67","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/ana.23784","article-title":"Diminished Th17 (not Th1) responses underlie multiple sclerosis disease abrogation after hematopoietic stem cell transplantation","volume":"73","author":"Darlington","year":"2013","journal-title":"Ann Neurol"},{"issue":"1","key":"2019111617453283500_B68","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1172\/JCI83840","article-title":"Rituximab does not reset defective early B cell tolerance checkpoints","volume":"126","author":"Chamberlain","year":"2016","journal-title":"J Clin Invest"},{"issue":"173","key":"2019111617453283500_B69","doi-asserted-by":"crossref","first-page":"173ra23","DOI":"10.1126\/scitranslmed.3005407","article-title":"CD19+CD24hiCD38hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiation","volume":"5","author":"Flores-Borja","year":"2013","journal-title":"Sci Transl Med"},{"issue":"3","key":"2019111617453283500_B70","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.immuni.2016.02.012","article-title":"A regulatory feedback between plasmacytoid dendritic cells and regulatory B cells is aberrant in systemic lupus erythematosus","volume":"44","author":"Menon","year":"2016","journal-title":"Immunity"},{"issue":"1","key":"2019111617453283500_B71","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.immuni.2009.11.009","article-title":"CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients","volume":"32","author":"Blair","year":"2010","journal-title":"Immunity"},{"issue":"16","key":"2019111617453283500_B72","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.1182\/blood-2012-11-465658","article-title":"Donor-derived regulatory B cells are important for suppression of murine sclerodermatous chronic graft-versus-host disease","volume":"121","author":"Le Huu","year":"2013","journal-title":"Blood"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/2\/2\/126\/879892\/advances011072.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/2\/2\/126\/879892\/advances011072.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,16]],"date-time":"2019-11-16T17:46:39Z","timestamp":1573926399000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/2\/2\/126\/16298\/Immune-rebound-associates-with-a-favorable"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,17]]},"references-count":72,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,1,23]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2017011072","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,17]]}}}